Researchers from the German Cancer Research Center (DKFZ) have collaborated with the SILVACX project group at Heidelberg University to develop a therapeutic vaccination concept that can mobilize the immune system to target cancer cells. The team showed that virus peptides coupled to silica nanoparticles can elicit effective T-cell responses against HPV-related tumors.

Knowing how shrews loose brain volume over winter is the first step to understanding how they reverse this loss and regrow healthy brains in summer.

The maturation process of oocytes remains paused for several years. Researchers from Konstanz and Göttingen have now found out which protein ensures this state is maintained over such a long period.

A team of scientists from the German Cancer Research Center (DKFZ) and the Netherlands Cancer Institute has discovered a previously unknown vulnerability in cancer cells: When cell division is blocked with chemotherapeutic agents such as Taxol, cancer cells produce small immunogenic peptides that could open up new avenues for immune-based cancer therapies.

Enhancing human perception of the imperceptible - 28/08/2025

AI-driven imaging expands possibilities in surgery

Doctors frequently experience a restricted view of the surgical field, particularly during endoscopic procedures. A novel technique developed by Prof. Dr. Lena Maier-Hein's team at the DKFZ in Heidelberg integrates spectral imaging with AI-driven data analysis. This innovation facilitates accurate tissue differentiation and delivers real-time insights into organ function.